Canadian Rheumatology Association/Spondyloarthritis Research Consortium of Canada Living Treatment Recommendations for the Management of Axial Spondyloarthritis: Update #1
Year: 2026
Type: article
Abstract: We have reviewed and updated the Canadian Rheumatology Association/Spondyloarthritis Research Consortium of Canada (CRA/SPARCC) living treatment recommendations for the management of axial spondyloarthritis (axSpA).1,2 Since its initial publication, the panel felt the need to reassess recommendations relating to treatment with interleukin-17 inhibitors (IL-17i).
Source: The Journal of Rheumatology
Authors: Nicolas Richard, Jordi Pardo Pardo, Reza Mirza, Sibel Z. Aydin, Louis Bessette, Dianne Mosher, Tristan Boyd, Jon Chan, Lihi Eder, Laura Passalent, Elie Karam, Bindu Nair, Glen S. Hazlewood, Shirley M.L. Tse, Dax G. Rumsey, Michel Zummer, Nigil Haroon, Robert Inman, Dafna D. Gladman, Sherry Rohekar
Institutions: Hôpital Maisonneuve-Rosemont, Université de Montréal, University of Ottawa, Ottawa Hospital Research Institute, McMaster University, Université Laval, University of Calgary, Western University, University of British Columbia, University of Toronto, Women's College Hospital, University Health Network, Krembil Research Institute, Schroeder Arthritis Institute, University of Saskatchewan, Hospital for Sick Children, University of Alberta, Toronto Western Hospital
Language: English
Subfield: Rheumatology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W7147239861
FWCI:
Cites:
Cited by:
Related to: